Patent Assignment
Reel/Frame 048002/0201
Security Interest
Recorded: 2019-01-03
Pages: 61
Assignor
LYCERA CORP.
Executed: 2019-01-02
Assignee
WILMINGTON TRUST, NATIONAL ASSOCIATION
50 SOUTH SIXTH STREET, SUITE 1290, MINNEAPOLIS, MINNESOTA, 55402
Covered Properties
(54)
Indazolyl-1,2,4-Thiadiazolamines and Related Compounds for Inhibition of Rho-Associated Protein Kinase and the Treatment of Disease
PCT:
PCT/US2017/048575 ↗
Indolinyl Sulfonamide and Related Compounds for Use as Agonists of Rory and the Treatment of Disease
PCT:
PCT/US2018/021657 ↗
Treatment of Cancer Using Aryl Dihydro-2H-Benzo[B][1,4]Oxazine Sulfonamide Compounds
PCT:
PCT/US2018/047902 ↗
N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
Rorgammat Inhibitors
Cycloalkyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
Pyridonyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
Pyrazolyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
Tetrahydronaphthyridine and Related Bicyclic Compounds for Inhibition of Rorgamma Activity and the Treatment of Disease
BICYCLIC SULFONE COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
Tetrahydro[1,8]naphthyridine Sulfonamide and Related Compounds for Use as Agonists of RORy and the Treatment of Disease
Indazole Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
Heterocyclic Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
Saturated Acyl Guanidine for Inhibition of F1F0-Atpase
4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
N-ALKYLATED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
3-CYCLOHEXENYL AND CYCLOHEXYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
Trifluoromethyl Pyrazolyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
Pyridonyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
RORgammaT INHIBITORS
Pyrazolyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
Trifluoromethyl Pyrazolyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
N-Substituted Pyrazolyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
Alkylpyrazolyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
2-ACYLAMIDOMETHYL AND SULFONYLAMIDOMETHYL BENZOXAZINE CARBAMATES FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
Carbamate Benzoxazine Propionic Acids and Acid Derivatives for Modulation of Rorgamma Activity and the Treatment of Disease
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
Adoptive Cellular Therapy Using an Agonist of Retinoic Acid Receptor-Related Orphan Receptor Gamma & Related Therapeutic Methods
Tetrahydro[1,8]naphthyridine Sulfonamide And Related Compounds for Use as Agonists of RORy and the Treatment of Disease
BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE
TETRAHYDROQUINOLINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE
Pyrazolyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
RORgammaT INHIBITORS
SUBSTITUTED PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
Indazolyl Thiadiazolamines and Related Compounds for Inhibition of Rho-Associated Protein Kinase and the Treatment of Disease
DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE
Aryl Dihydro-2H-Benzo[B][1,4]Oxazine Sulfonamide and Related Compounds for Use as Agonists of Rory and the Treatment of Disease
Tetrahydronaphthyridine and Related Bicyclic Compounds for Inhibition of Rorgamma Activity and the Treatment of Disease
Trifluoromethyl Pyrazolyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
4-Heteroaryl Substituted Benzoic Acid Compounds as Rorgammat Inhibitors and Uses Thereof
Tetrahydro[1,8]Naphthyridine Sulfonamide and Related Compounds for Use as Agonists of Rory and the Treatment of Disease
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
SUBSTITUTED INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
HETEROARYL SUBSTITUTED BENZOIC ACIDS AS RORgammaT INHIBITORS AND USES THEREOF
TETRAHYDROQUINOLINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE
Tetrahydroquinoline Sulfonamide and Related Compounds for Use as Agonists of Rory and the Treatment of Disease
N-Substituted Pyrazolyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
Pyrazolyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
Application:
15/920,690 →
Publication:
US 2018/0334438
Trifluoromethyl Pyrazolyl Guanidine F1F0-Atpase Inhibitors and Therapeutic Uses Thereof
Application:
16/123,051 →
Publication:
US 2019/0175556
Treatment of Cancer Using Aryl Dihydro-2H-Benzo[B][1,4]Oxazine Sulfonamide Compounds
Application:
62/632,496 →
Methods of Treating Cancer Using Aryl Dihydro-2H-Benzo[B][1,4]Oxazine Sulfonamide Compounds
Application:
62/632,502 →
Dihydroisoquinoline-2(1H)-Carboxamide and Related Compounds and Their Use in Treating Medical Conditions
Application:
62/656,167 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 14, 2013
From: KARSTENS, WILLEM FREDERIK JOHAN; VAN DER STELT, MARIO; CALS, JOS; AZEVEDO, RITA CORTE REAL GONCALVES
To: MERCK SHARP & DOHME BV
Reel/Frame 031398/0507 →
Confirmatory Assignment
Oct 14, 2013
From: SHANGPHARMA CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 031407/0093 →
Assignment of Assignor's Interest
Oct 14, 2013
From: BERESIS, RICHARD THOMAS; ZHANG, DONGSHAN; DUAN, XIAOBANG
To: SHANGPHARMA CORPORATION
Reel/Frame 031398/0578 →
Assignment of Assignor's Interest
Oct 14, 2013
From: BARR, KENNETH JAY; ZHANG, HONGJUN
To: MERCK SHARP & DOHME CORP.
Reel/Frame 031398/0536 →
Assignment of Assignor's Interest
Mar 14, 2014
From: NANOSYN INC.
To: LYCERA CORPORATION
Reel/Frame 032439/0564 →
Assignment of Assignor's Interest
Dec 8, 2014
From: NANOSYN INC.
To: LYCERA CORPORATION
Reel/Frame 034427/0435 →
Assignment of Assignor's Interest
Dec 8, 2014
From: AICHER, THOMAS DANIEL; TOOGOOD, PETER L.; VAN HUIS, CHAD A.
To: LYCERA CORPORATION
Reel/Frame 034427/0214 →
Assignment of Assignor's Interest
Dec 8, 2014
From: STEIN, KARIN ANN; THOMAS, WILLIAM DAVID
To: NANOSYN INC.
Reel/Frame 034427/0399 →
Assignment of Assignor's Interest
Dec 8, 2014
From: AICHER, THOMAS DANIEL; TOOGOOD, PETER L.; VAN HUIS, CHAD A.
To: LYCERA CORPORATION
Reel/Frame 034427/0573 →
Assignment of Assignor's Interest
Dec 8, 2014
From: THOMAS, WILLIAM DAVID
To: NANOSYN INC.
Reel/Frame 034427/0609 →
Assignment of Assignor's Interest
Dec 8, 2014
From: NANOSYN INC.
To: LYCERA CORPORATION
Reel/Frame 034427/0632 →
Assignment of Assignor's Interest
Dec 22, 2014
From: BARR, KENNETH JAY; SIMOV, VLADIMIR
To: MERCK SHARP & DOHME CORP.
Reel/Frame 034570/0853 →
Assignment of Assignor's Interest
Dec 22, 2014
From: BARR, KENNETH JAY; LAPOINTE, BLAIR T.; SIMOV, VLADIMIR; WHITE, CATHERINE M.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 034570/0782 →
Assignment of Assignor's Interest
Jun 1, 2015
From: WANG, JIAN; ZHOU, PENG
To: CRYSTAL PHARMATECH
Reel/Frame 035756/0799 →
Assignment of Assignor's Interest
Jun 1, 2015
From: CRYSTAL PHARMATECH
To: LYCERA CORPORATION
Reel/Frame 035756/0818 →
Assignment of Assignor's Interest
Jul 29, 2015
From: HURD, ALEXANDER R.; TAYLOR, CLARKE B.
To: LYCERA CORPORATION
Reel/Frame 036210/0104 →
Assignment of Assignor's Interest
Sep 11, 2015
From: BARR, KENNETH JAY; BIENSTOCK, COREY; MACLEAN, JOHN; ZHANG, HONGJUN
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036545/0274 →
Assignment of Assignor's Interest
Sep 11, 2015
From: BARR, KENNETH JAY; BIENSTOCK, COREY; MACLEAN, JOHN; ZHANG, HONGJUN
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036545/0142 →
Assignment of Assignor's Interest
Sep 11, 2015
From: SHANGHAI CHEMPARTNER CO. LTD.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036545/0622 →
Assignment of Assignor's Interest
Sep 11, 2015
From: SHANGHAI CHEMPARTNER CO. LTD.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036545/0542 →
Assignment of Assignor's Interest
Sep 11, 2015
From: BERESIS, RICHARD THOMAS; ZHANG, DONGSHAN
To: SHANGHAI CHEMPARTNER CO. LTD.
Reel/Frame 036545/0476 →
Assignment of Assignor's Interest
Sep 11, 2015
From: BERESIS, RICHARD THOMAS; ZHANG, DONGSHAN
To: SHANGHAI CHEMPARTNER CO. LTD.
Reel/Frame 036545/0391 →
Assignment of Assignor's Interest
Nov 17, 2015
From: HURD, ALEXANDER R.; TAYLOR, CLARKE B.; TOOGOOD, PETER L.
To: LYCERA CORPORATION
Reel/Frame 037062/0635 →
Assignment of Assignor's Interest
Apr 1, 2016
From: BARR, KENNETH JAY; MACLEAN, JOHN; ZHANG, HONGJUN; ANDRESEN, BRIAN
To: MERCK SHARP & DOHME CORP.
Reel/Frame 038172/0843 →
Assignment of Assignor's Interest
Apr 1, 2016
From: SHANGHAI CHEMPARTNER CO. LTD.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 038173/0536 →